Chemed (NYSE:CHE) - Aktienkurs, Nachrichten und Analyse

CHE Aktienübersicht

CHE grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	2/6
Künftiges Wachstum	1/6
Vergangene Leistung	6/6
Finanzielle Gesundheit	6/6
Dividenden	0/6

Belohnungen

15.5% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 13.08% pro Jahr

Die Erträge stiegen im vergangenen Jahr um 18.3%

Analysten sind sich einig, dass der Aktienkurs um 28.7%

Risikoanalyse

Signifikante Insiderverkäufe in den letzten 3 Monaten

Chemed Corporation Wettbewerber

DaVita

NYSE:DVA

US$12.4b

Option Care Health

NasdaqGS:OPCH

US$4.9b

Quest Diagnostics

NYSE:DGX

US$15.4b

CorVel

NasdaqGS:CRVL

US$4.2b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Chemed
Historische Aktienkurse
Aktueller Aktienkurs	US$542.47
52-Wochen-Hoch	US$654.62
52-Wochen-Tief	US$492.84
Beta	0.46
11 Monat Veränderung	-2.32%
3 Monate Veränderung	-15.87%
1 Jahr Veränderung	0.11%
33 Jahre Veränderung	10.95%
5 Jahre Veränderung	50.34%
Veränderung seit IPO	4,695.31%

Aktuelle Nachrichten und Updates

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Recent updates

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16

Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns

Aug 26

A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Aug 16

Chemed declares $0.38 dividend

Aug 05

Chemed Q2 results mixed, co increases top end of FY 2022 adj. EPS guidance range

Jul 27

Is Chemed (NYSE:CHE) A Risky Investment?

Jun 29

Chemed announces a five-year $550M amended and restated senior secured credit facility

Jun 29

Returns on Capital Paint A Bright Future For Chemed (NYSE:CHE)

Jun 14

Estimating The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

May 14

Aktionärsrenditen

	CHE	US Healthcare	US Markt
7D	0.7%	-0.9%	0.5%
1Y	0.1%	2.7%	23.7%

Rendite im Vergleich zur Industrie: CHE unter dem Niveau der Branche US Healthcare , die im vergangenen Jahr eine Rendite von 3.5% erzielte.

Rendite vs. Markt: CHE hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 22.3 erzielte.

Preisvolatilität

Is CHE's price volatile compared to industry and market?
CHE volatility
CHE Average Weekly Movement	2.8%
Healthcare Industry Average Movement	6.8%
Market Average Movement	5.7%
10% most volatile stocks in US Market	15.4%
10% least volatile stocks in US Market	2.8%

Stabiler Aktienkurs: CHE hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: CHEDie wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1970	15,087	Kevin McNamara	www.chemed.com

Die Chemed Corporation bietet Hospiz- und Palliativpflegeleistungen für Patienten über ein Netz von Ärzten, Krankenschwestern und -pflegern, häuslichen Gesundheitshelfern, Sozialarbeitern, Geistlichen und Freiwilligen hauptsächlich in den Vereinigten Staaten an. Das Unternehmen ist in den Segmenten VITAS und Roto-Rooter tätig. Es bietet Klempnerarbeiten, Abflussreinigung, Aushubarbeiten, Wassersanierung und andere damit verbundene Dienstleistungen für private und gewerbliche Kunden über firmeneigene Niederlassungen, unabhängige Auftragnehmer und Franchisenehmer an.

Chemed Corporation's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Chemed im Vergleich zum Marktanteil des Unternehmens?
CHE grundlegende Statistiken
Marktanteil	US$8.18b
Gewinn(TTM)	US$283.41m
Umsatz(TTM)	US$2.29b

28.9x

Kurs-Gewinn-Verhältnis

3.6x

Kurs-Umsatz-Verhältnis

Ist CHE zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
CHE Gewinn- und Verlustrechnung (TTM)
Einnahmen	US$2.29b
Kosten der Einnahmen	US$1.48b
Bruttogewinn	US$813.47m
Sonstige Ausgaben	US$530.06m
Umsatz	US$283.41m

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	18.79
Bruttomarge	35.47%
Nettogewinnspanne	12.36%
Schulden/Eigenkapital-Verhältnis	0%

Wie hat sich CHE auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

0.3%

Aktuelle Dividendenrendite

8%

Ausschüttungsquote

CHE Aktienübersicht

Belohnungen

Risikoanalyse

Chemed Corporation Wettbewerber

NYSE:DVA

US$12.4b

NasdaqGS:OPCH

US$4.9b

NYSE:DGX

US$15.4b

NasdaqGS:CRVL

US$4.2b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

CEO, President & Director recently sold US$816k worth of stock

CEO, President & Director notifies of intention to sell stock

First quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on June 18, 2024

Chemed: Growth Does Not Justify The Current Stock Price

CEO, President & Director recently sold US$2.3m worth of stock

Recent updates

CEO, President & Director recently sold US$816k worth of stock

CEO, President & Director notifies of intention to sell stock

First quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on June 18, 2024

Chemed: Growth Does Not Justify The Current Stock Price

CEO, President & Director recently sold US$2.3m worth of stock

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation Reiterates Earnings Guidance for Full Year 2024

First quarter 2024 earnings: EPS misses analyst expectations

Chemed Corporation, Annual General Meeting, May 20, 2024

New major risk - Revenue and earnings growth

Executive Vice President exercised options and sold US$3.8m worth of stock

Executive Vice President recently sold US$1.3m worth of stock

Chemed Corporation to Report Q1, 2024 Results on Apr 24, 2024

Price target increased by 10% to US$690

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 22% overvalued after recent price rise

Third quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on March 15, 2024

Chemed Corporation to Report Q4, 2023 Results on Feb 27, 2024

The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed Corporation Appoints Michael D. Witzeman as Chief Financial Officer, Effective January 1, 2024

CEO, President & Director recently sold US$859k worth of stock

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Executive Vice President recently sold US$580k worth of stock

Executive VP & CFO notifies of intention to sell stock

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Executive VP & CFO exercised options to buy US$5.9m worth of stock.

CEO, President & Director recently sold US$1.7m worth of stock

Chemed Corporation Provides Earnings Guidance for the Full-Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Corporation to Report Q3, 2023 Results on Oct 25, 2023

Chemed - Showcasing Why It's So Reliable

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

CEO, President & Director recently sold US$2.1m worth of stock

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Corporation to Report Q2, 2023 Results on Jul 26, 2023

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Executive Vice President notifies of intention to sell stock

Independent Director recently sold US$160k worth of stock

Independent Director notifies of intention to sell stock

CEO, President & Director recently sold US$2.2m worth of stock

CEO, President & Director exercised options and sold US$412k worth of stock

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

CEO, President & Director recently sold US$1.6m worth of stock

Executive VP & CFO recently sold US$2.1m worth of stock

CEO, President & Director recently sold US$1.0m worth of stock

CEO, President & Director exercised options to buy US$1.2m worth of stock.

Full year 2022 earnings: EPS misses analyst expectations

Chemed Q4 2022 Earnings Preview

Chemed Corporation Declares Quarterly Cash Dividend Payable on March 17, 2023

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Erträge & Einnahmen